Highlands Oncology

Springdale, Arkansas 72762

0 studies enrolling now · 10 studies all time

What they study most

Advanced Solid Tumor, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, B Cell Lymphoma, Bile Duct Cancer, Breast Tumor, Castrate Resistant Prostate Cancer, Cholangiocarcinoma, Colon Tumor, Malignant, Colorectal Cancer, Colorectal Neoplasms, EGFR Exon 19 Deletion, EGFR L858R

Studies at this site

• A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors — Stopped early
• A Study of PF-06873600 in People With Cancer — Stopped early
• Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors — Stopped early
• A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors — Stopped early
• Medical Access Program for Patritumab Deruxtecan — NO_LONGER_AVAILABLE
• A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer — Running, not enrolling
• HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy — Running, not enrolling
• SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation — Stopped early
• Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors — Stopped early
• Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas — Status unconfirmed